Predictive Oncology Inc.
POAI
$1.06
-$0.03-2.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.56% | 28.74% | 43.71% | 54.95% | 57.96% |
| Total Depreciation and Amortization | -3.79% | 12.52% | -21.90% | -29.88% | -28.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.61% | -91.32% | -91.56% | -95.92% | -95.80% |
| Change in Net Operating Assets | 67.37% | -106.57% | -101.90% | -72.22% | -177.23% |
| Cash from Operations | 33.41% | 27.17% | 0.95% | -3.72% | -6.62% |
| Capital Expenditure | 96.41% | 101.78% | 101.29% | 39.11% | 37.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 74.05% | 82.52% | 72.45% | 38.60% |
| Cash from Investing | 96.86% | 99.41% | 98.81% | 41.48% | 36.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -215.30% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 93.64% | 94.57% | 94.57% | 94.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,948.96% | 1,225.19% | 12,402.90% | -99.45% | -97.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.97% | 51.16% | 30.06% | -105.57% | -117.63% |